Buprenorphine with naloxone sublingual tab 8 mg with naloxone 2 mg: Supply issue
There may be a supply issue affecting buprenorphine with naloxone (pharmacode 2574012 - sublingual tab 8 mg with naloxone 2 mg)
Affected product
We expect that there will not be a complete out of stock of this product. However, stock is low of:
- Chemical: Buprenorphine with naloxone
- Presentation: Tab sublingual 8 mg with naloxone 2 mg
- Brand: Buprenorphine Naloxone BNM
- Pharmacode: 2574012
- Subsidy: $34.00
- Measure / Qty: per 28
The 2 mg / 0.5 mg tablet (Pharmacode 2574004) is not affected.
Schedule listing for buprenorphine with naloxone(external link)
Expected resolution
Stock is available until early January 2025. A sea freight shipment is expected at about the same time, however that will take time to clear quality assurance and be distributed to pharmacies around the motu.
The supplier is organising a small amount of stock to be flown to New Zealand to cover any shortfall.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)